trial

Cognitive Behavioral Treatment for Post-Traumatic Stress Disorder in People With Additional Serious Mental Illnesses

NCTId NCT00494650
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 200 (actual)
Sponsored by Dartmouth-Hitchcock Medical Center
Primary completion 2012-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
200 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2008-04
Primary completion
2012-07
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Cognitive Behavioral Therapy (CBT)Brief PTSD treatment

Sponsors

Dartmouth-Hitchcock Medical CenterLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Kim T. Mueser, PhDPrincipal Investigator

Sites

5 total
Monmouth Junction, United StatesNew Brunswick, United StatesNew Brunswick, United StatesNewark, United StatesNewark, United States

Facts & assertions

4 sourced
Enrollment
200
Phase
NA
Primary Completion Date
2012-07
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive Behavioral Therapy (CBT)
drug
Brief PTSD treatment
drug
lead_sponsor
Dartmouth-Hitchcock Medical Center
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Bipolar Disorder
indication
Post-traumatic Stress Disorder
indication
Depressive Disorder, Major
indication
investigator
Kim T. Mueser, PhD
person